$ATRA Atara Biotherapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Atara Biotherapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Atara Biotherapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Atara Biotherapeutics, Inc. for free.

CIK Number: 0001604464
IRS Number: 460920988
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: ATRA
Company Address: 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO 94080

Atara Biotherapeutics, Inc. operates as a clinical stage company which focuses on developing novel therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology. Its product candidates are biologics targeting myostatin and activin, members of the transforming growth factor-beta, protein superfamily, which play roles in the growth and maintenance of muscle and many other body tissues. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA.

Market Capitalization: $434.34M
Prev close: $15.05
Average Daily Volume: 231,402
Days Low: $14.70
Year Low: $12.45
Year High: $25.73

Atara Biotherapeutics, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Berger DietmarGlobal Head of R&D50,000752,500shares bought: 50,000 / shares sold: 0 BUYMay 07 20182 months ago
Ciechanover Isaac E.Chief Executive Officer168,0782,529,574shares bought: 595,292 / shares sold: -840,557 SELLJun 06 201817 days ago
Clark Mitchall G.EVP & Chief R & QA Officer107,9721,624,979shares bought: 209,754 / shares sold: -185,246 BUYMay 21 20181 month ago
DOBMEIER ERICDirector14,000210,700shares bought: 11,500 / shares sold: 0 STRONG BUYJun 18 20185 days ago
Fust Matthew KDirector21,854328,903shares bought: 20,252 / shares sold: -12,286 BUYJun 18 20185 days ago
Gallagher Carol GiltnerDirector110,5921,664,410shares bought: 27,971 / shares sold: -12,059 STRONG BUYJun 19 20184 days ago
Haqq ChristopherEVP, R&D & Chief Scientific Of357,9055,386,470shares bought: 188,357 / shares sold: -151,467 BUYMay 16 20181 month ago
HEIDEN WILLIAM KDirector8,500127,925shares bought: 10,000 / shares sold: 0 STRONG BUYJun 18 20185 days ago
Kim MinaSenior VP & General Counsel42,500639,625shares bought: 170,000 / shares sold: 0 STRONG BUYApr 09 20183 months ago
Koppikar UtpalChief Financial Officer45,000677,250shares bought: 45,000 / shares sold: 0 BUYJun 07 201816 days ago
MARCUS JOEL SDirector8,500127,925shares bought: 8,500 / shares sold: 0 STRONG BUYJun 18 20185 days ago
Newell JoeChief Tech. Operations Officer31,858479,463shares bought: 32,500 / shares sold: -642 STRONG BUYApr 04 20183 months ago
Porter DerrellSVP, Head of Global Commercial28,834433,952shares bought: 28,834 / shares sold: -17,878 BUYMay 16 20181 month ago
SEIDENBERG BETH CDirector15,189228,594shares bought: 8,500 / shares sold: 0 STRONG BUYJun 18 20185 days ago
Sofer GadEVP & Chief Strategy Officer266,5064,010,915shares bought: 218,600 / shares sold: -78,486 STRONG BUYMay 16 20181 month ago

View all Atara Biotherapeutics, Inc. insiders.

Atara Biotherapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 19 2018ATRAAtara Biotherapeut ...Gallagher Carol GiltnerDirectorSellS45.2940018,116110,192110.6 K to 110.2 K (-0.36 %)
Jun 19 2018ATRAAtara Biotherapeut ...Gallagher Carol GiltnerDirectorSellS44.682,10093,828110,592112.7 K to 110.6 K (-1.86 %)
Jun 18 2018ATRAAtara Biotherapeut ...SEIDENBERG BETH CDirectorOption ExerciseA45.655,000228,2505,000
Jun 18 2018ATRAAtara Biotherapeut ...SEIDENBERG BETH CDirectorGrantA0.001,500015,18913.7 K to 15.2 K (+10.96 %)
Jun 18 2018ATRAAtara Biotherapeut ...HEIDEN WILLIAM KDirectorOption ExerciseA45.655,000228,2505,000
Jun 18 2018ATRAAtara Biotherapeut ...HEIDEN WILLIAM KDirectorGrantA0.001,50008,5007 K to 8.5 K (+21.43 %)
Jun 18 2018ATRAAtara Biotherapeut ...MARCUS JOEL SDirectorOption ExerciseA45.655,000228,2505,000
Jun 18 2018ATRAAtara Biotherapeut ...MARCUS JOEL SDirectorGrantA0.001,50008,5007 K to 8.5 K (+21.43 %)
Jun 18 2018ATRAAtara Biotherapeut ...Gallagher Carol GiltnerDirectorOption ExerciseA45.655,000228,2505,000
Jun 18 2018ATRAAtara Biotherapeut ...Gallagher Carol GiltnerDirectorGrantA0.001,5000112,692111.2 K to 112.7 K (+1.35 %)
Jun 18 2018ATRAAtara Biotherapeut ...Fust Matthew KDirectorOption ExerciseA45.655,000228,2505,000
Jun 18 2018ATRAAtara Biotherapeut ...Fust Matthew KDirectorGrantA0.001,500021,85420.4 K to 21.9 K (+7.37 %)
Jun 18 2018ATRAAtara Biotherapeut ...DOBMEIER ERICDirectorOption ExerciseA45.655,000228,2505,000
Jun 18 2018ATRAAtara Biotherapeut ...DOBMEIER ERICDirectorGrantA0.001,500014,00012.5 K to 14 K (+12.00 %)
Jun 07 2018ATRAAtara Biotherapeut ...Koppikar UtpalChief Financial Off ...Option ExerciseA42.3075,0003,172,50075,000

View all Atara Biotherapeutics, Inc. insider transactions.